Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UVT Allograft for Recurrent Stress Urinary Incontinence
NCT05207189Phase 2Completed
- Sponsor
- TBF Génie Tissulaire
- Start
- Nov 2021
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in stress urinary incontinence (SUI), sponsored by TBF Génie Tissulaire. Primary endpoints: No major signs of incontinence at 6 months and No complication related to investigational product at 6 months. Started Nov 2021; status: completed.
02
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT05207189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05207189.